Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
about
Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumorsCirculating glioma biomarkersRevisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formationAdaptation to antiangiogenic therapy in neurological tumorsInduction of vascular endothelial growth factor receptor expression in human umbilical vein endothelial cells after repeated bevacizumab treatment in vitro.In vitro modeling of the neurovascular environment by coculturing adult human brain endothelial cells with human neural stem cellsSystemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma.Therapeutic efficacy of aldoxorubicin in an intracranial xenograft mouse model of human glioblastoma.Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia.Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomasPhase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumorsImmunotherapy for malignant gliomaAll-trans retinoic acid impairs the vasculogenic mimicry formation ability of U87 stem-like cells through promoting differentiation.Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets.Wnt3a Promotes the Vasculogenic Mimicry Formation of Colon Cancer via Wnt/β-Catenin SignalingVB-111: a novel anti-vascular therapeutic for glioblastoma multiformeTalin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme.Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model.Acquisition of tumorigenic potential and enhancement of angiogenesis in pulmonary stem/progenitor cells through Oct-4 hyperexpression.Human neural stem cell-induced endothelial morphogenesis requires autocrine/paracrine and juxtacrine signaling.Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurementsEmerging biomarkers in glioblastomaAntiangiogenic cancer treatment: The great discovery and greater complexity (Review).Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models.Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft ModelsResistance to antiangiogenic therapy.Recent advances in vascular disrupting agents in cancer therapy.Apatinib for the treatment of gastric cancer.Epithelioid glioblastoma presenting as massive intracerebral hemorrhage: Case report and review of the literature.Recent advance in molecular angiogenesis in glioblastoma: the challenge and hope for anti-angiogenic therapy.Tumor cell vascular mimicry: Novel targeting opportunity in melanoma.Evaluation of neovascularization patterns in an orthotopic rat glioma model with dynamic contrast-enhanced MRI.Prognostic value of preoperative von Willebrand factor plasma levels in patients with GlioblastomaGlucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion.Vascular Mimicry: The Next Big Glioblastoma Target.Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells.High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study.VEGFR2 regulates endothelial differentiation of colon cancer cells.Deficiency in matrix metalloproteinase-2 results in long-term vascular instability and regression in the injured mouse spinal cord.Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
P2860
Q26773795-81E0D0CF-0987-49E8-BFC5-218B31CF0838Q26830329-20FFE282-A808-44CA-B9B7-06D0E8343750Q28077123-DDC92D5F-E5E5-4B02-A3E6-E5D59C943DC8Q28082908-6C83F0F4-81A7-406A-A9AC-B9A2133DBD54Q33912461-36FDDB66-52E9-4B0D-B018-A45657F6EDF0Q34133797-39022D31-0ED8-4D99-AC76-C5BAF9B4700DQ34334362-732C34EB-2260-4EC1-B21F-A38935E0E92FQ34417525-6D16CB52-5A82-41FF-BBB6-1AF1B88CB206Q34786452-D02E43FC-D581-466D-A3ED-3F620C203F57Q34807753-CB8C1118-E697-49F8-B127-05C800A16F7BQ34964958-76929DC5-AEC1-4DFA-80A3-0897CADB94C3Q35114086-13BD81E8-09C1-44D9-8ED3-84EBCD3C7B96Q35628364-BB5A80BD-9BB9-4748-A149-796F33730E63Q35748107-45616933-F7D0-4D19-A448-F53446F89C47Q36088595-140A766D-3442-4968-8D76-2E8FFBFCA6B0Q36096024-F7B0A9D0-A73F-4CCF-A784-E7C16949FE23Q36413742-64AE19B6-52BA-4174-BD9A-5B2CF2026062Q36484434-61DEAC74-D761-4274-ABC0-761C64AA4F27Q37046488-B6872940-BCEC-4AA1-B30B-6324AE520958Q37061645-6C3378A1-C2C0-4ADF-BA0D-E38FF27FAA89Q37143641-9723184F-CF1A-418B-822B-72980907F112Q37226521-396B2CFA-EA8E-4CC7-BD01-30556B488309Q37337814-FB0C6470-9E5A-4E4B-96CA-E2A8045FFFC6Q37407395-15811AF2-B8BA-4855-A1A5-62D22D8B46B3Q37615383-8A54411B-7D88-49B3-A0C6-C95EC2CFD529Q38197943-B1FBB1E2-C677-4EDF-9B01-E2A96D399475Q38264533-87E531C9-3C2C-4A03-A2D3-92ED0A37EB79Q38270899-FF16331C-1B58-44A1-B436-27C09D790E0DQ38425632-C6CE04AE-5866-40BC-9410-02C1E909AAAFQ38599484-742FF72B-60A7-4C2E-8DB2-2DD10CCD3629Q38710798-15FDAD2A-8054-4BE4-8BA1-499D27F9AC5FQ38783784-7715FFC8-E404-44EF-8202-F8CBBED0D79BQ38861130-C05309B0-EB94-48F6-B982-B3DE7FEDAB88Q38977444-C567BF61-B7F1-44B7-B851-246653770304Q39691814-9B7CBB71-D54D-440F-B38A-BF682957140EQ41092476-8E974C70-A01C-4F91-99A8-AC0370997033Q41259845-63B578B4-A5DF-4FAC-B985-BD389E319308Q41570454-AF26595D-0833-4369-B2AF-F9E763BE43CEQ41641630-F4DDDA6E-CDA3-46F2-9044-C242AD715D3EQ41912135-5A211278-15F2-413B-AA36-EA8FCA451CEA
P2860
Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mechanisms of neovascularizati ...... ies in glioblastoma multiforme
@ast
Mechanisms of neovascularizati ...... ies in glioblastoma multiforme
@en
Mechanisms of neovascularizati ...... ies in glioblastoma multiforme
@nl
type
label
Mechanisms of neovascularizati ...... ies in glioblastoma multiforme
@ast
Mechanisms of neovascularizati ...... ies in glioblastoma multiforme
@en
Mechanisms of neovascularizati ...... ies in glioblastoma multiforme
@nl
prefLabel
Mechanisms of neovascularizati ...... ies in glioblastoma multiforme
@ast
Mechanisms of neovascularizati ...... ies in glioblastoma multiforme
@en
Mechanisms of neovascularizati ...... ies in glioblastoma multiforme
@nl
P2093
P2860
P3181
P1476
Mechanisms of neovascularizati ...... ies in glioblastoma multiforme
@en
P2093
Amy Rommel
Chad Myskiw
Inder M. Verma
Yasushi Soda
P2860
P2888
P304
P3181
P356
10.1007/S00109-013-1019-Z
P407
P577
2013-04-01T00:00:00Z
P6179
1028171373